A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists
- PMID: 2567672
- DOI: 10.1007/BF00558306
A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists
Abstract
The hypokalaemic effects of equal doses (5 mg) of fenoterol, salbutamol, terbutaline and an equal volume of saline administered by nebulization were compared in eight healthy subjects. Plasma potassium was measured at 15-min intervals for 60 min and at 90 min, 2, 4 and 6 h following administration. Fenoterol, salbutamol and terbutaline all significantly decreased plasma potassium when compared to saline; however, the magnitude and duration of this effect differed between the active agents. Both fenoterol and terbutaline significantly reduced plasma potassium for 4 h whereas salbutamol was only different from 30 to 120 min. The maximum decrease occurred with fenoterol (-0.78 mmol/l), followed by terbutaline (-0.70 mmol/l) and salbutamol (-0.33 mmol/l). Both terbutaline and fenoterol had a significantly greater effect compared with salbutamol. When administered by nebulization fenoterol and terbutaline are likely to have a greater hypokalaemic effect than salbutamol and this effect is likely to be more long lasting.
Similar articles
-
Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.Eur J Clin Invest. 1988 Apr;18(2):162-5. doi: 10.1111/j.1365-2362.1988.tb02407.x. Eur J Clin Invest. 1988. PMID: 2898368 Clinical Trial.
-
Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.Br J Clin Pharmacol. 1987 Nov;24(5):645-53. doi: 10.1111/j.1365-2125.1987.tb03224.x. Br J Clin Pharmacol. 1987. PMID: 2829953 Free PMC article. Clinical Trial.
-
Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.J Asthma. 1996;33(6):407-15. doi: 10.3109/02770909609068185. J Asthma. 1996. PMID: 8968295 Clinical Trial.
-
Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):342-62. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1358833 Review.
-
[Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics].Nihon Rinsho. 1996 Nov;54(11):3081-6. Nihon Rinsho. 1996. PMID: 8950959 Review. Japanese.
Cited by
-
Rejection of hemolyzed samples can jeopardize patient safety.EJIFCC. 2020 Mar 20;31(1):15-20. eCollection 2020 Mar. EJIFCC. 2020. PMID: 32256285 Free PMC article.
-
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.Postgrad Med J. 1990 Feb;66(772):98-101. doi: 10.1136/pgmj.66.772.98. Postgrad Med J. 1990. PMID: 2349198 Free PMC article. Clinical Trial.
-
Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM).Eur J Clin Pharmacol. 1995;49(1-2):31-6. doi: 10.1007/BF00192355. Eur J Clin Pharmacol. 1995. PMID: 8751018
-
Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.Thorax. 2003 Jan;58(1):43-6. doi: 10.1136/thorax.58.1.43. Thorax. 2003. PMID: 12511719 Free PMC article.
-
Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.Eur J Clin Pharmacol. 1996;49(5):341-5. doi: 10.1007/BF00203774. Eur J Clin Pharmacol. 1996. PMID: 8866625 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources